Skip to content

Food and Drug Regulations

C.R.C., c. 870

In forceCurrent to September 30, 2026 HistoryMade under: Food and Drugs Act

Follow

Part C — Drugs › Division 5 — Drugs for Clinical Trials Involving Human Subjects

Prohibition

Section C.05.003

Amended on June 4, 2026

 Despite sections C.01.014, C.08.002, C.08.002.02 and C.08.003, no person shall sell or import a drug for the purposes of a clinical trial unless

  • (a) the person is authorized under this Division;

  • (b) the person complies with this Division and sections C.01.015, C.01.036, C.01.037 to C.01.040, C.01.040.2, C.01.064 to C.01.067, C.01.070, C.01.134 to C.01.136, and C.01.435; and

  • (c) if the drug is to be imported, the person has a representative in Canada who is responsible for the sale of the drug.

  • SOR/2001-203, s. 4
  • SOR/2011-88, s. 7
  • SOR/2026-113, s. 12
.

Amended by SOR/2026-113, s. 12, in force on June 4, 2026

Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.